Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubChem Compound

Items: 1 to 20 of 176

1.

Synthesis of two thermo-responsive copolymers forming recyclable aqueous two-phase systems and its application in cefprozil partition.

Hou D, Cao X.

J Chromatogr A. 2014 Jul 4;1349:30-6. doi: 10.1016/j.chroma.2014.04.075. Epub 2014 Apr 28.

PMID:
24857035
2.

The management of acute mastoiditis in children with cochlear implants: saving the device.

Osborn HA, Cushing SL, Gordon KA, James AL, Papsin BC.

Cochlear Implants Int. 2013 Nov;14(5):252-6. doi: 10.1179/1754762813Y.0000000049. Epub 2013 Aug 30.

PMID:
23998418
3.

HPLC determination of cefprozil in tablets using monolithic and C18 silica columns.

Can NO.

J Sep Sci. 2011 Aug;34(16-17):2223-31. doi: 10.1002/jssc.201100170. Epub 2011 May 6.

PMID:
21557474
4.

Management of pain after tonsillectomy: a prospective, randomized clinical study.

Inci N, Basut O, Kasapoğlu F, Coşkun H.

Kulak Burun Bogaz Ihtis Derg. 2009 Jan-Feb;19(1):1-8.

PMID:
19793040
5.

Acute generalized exanthematous pustulosis with severe organ dysfunction.

Leclair MA, Maynard B, St-Pierre C.

CMAJ. 2009 Sep 15;181(6-7):393-6. doi: 10.1503/cmaj.090137. Epub 2009 Jul 20. No abstract available.

6.

The stability of cefprozil in oral suspension CEFZIL.

Jelińska A, Medenecka B, Zajac M, Knajsiak M.

Acta Pol Pharm. 2008 Mar-Apr;65(2):261-5.

7.

Comparison of the efficacies of oral beta-lactams in selection of Haemophilus influenzae transformants with mutated ftsI genes.

Takahata S, Kato Y, Sanbongi Y, Maebashi K, Ida T.

Antimicrob Agents Chemother. 2008 May;52(5):1880-3. doi: 10.1128/AAC.00936-07. Epub 2008 Mar 17.

8.

Redefining the management of pediatric tonsillopharyngitis with cefprozil.

Jerath N, Shetty G.

Indian J Pediatr. 2007 Dec;74(12):1105-8. Review.

PMID:
18174646
9.

Pharmacokinetics of cefprozil in plasma and middle ear fluid: in children undergoing treatment for acute otitis media.

Nicolau DP, Sutherland CA, Arguedas A, Dagan R, Pichichero ME.

Paediatr Drugs. 2007;9(2):119-23.

PMID:
17407367
10.

A rare case of hepatitis associated with cefprozil therapy.

Bilici A, Karaduman M, Cankir Z.

Scand J Infect Dis. 2007;39(2):190-2.

PMID:
17366046
11.

Comparative effects of single-dose ceftriaxone versus three oral antibiotic regimens on stool colonization by resistant bacilli in children.

Toltzis P, Dul M, O'Riordan MA, Toltzis H, Blumer JL.

Pediatr Infect Dis J. 2007 Jan;26(1):25-30.

PMID:
17195701
12.

Pharmacodynamics of cefprozil against Haemophilus influenzae in an in vitro pharmacodynamic model.

Smith PF, Tsuji B, Booker BM, Forrest A, Bajic S, Kelchlin P, Bhavnani SM, Jones RN, Ambrose PG.

Diagn Microbiol Infect Dis. 2006 Dec;56(4):379-86. Epub 2006 Aug 23.

PMID:
16930921
13.
14.

Flow-injection chemiluminescent determination of cefprozil using Tris (2,2'-bipyridyl) ruthenium (II)-permanganate system.

Alarfaj NA, Abd El-Razeq SA.

J Pharm Biomed Anal. 2006 Jun 16;41(4):1423-7. Epub 2006 May 6.

PMID:
16682164
16.

Adverse antibiotic-induced eruptions associated with epstein barr virus infection and showing Kikuchi-Fujimoto disease-like histology.

Carlson JA, Perlmutter A, Tobin E, Richardson D, Rohwedder A.

Am J Dermatopathol. 2006 Feb;28(1):48-55.

PMID:
16456326
17.

[Cefprozil in the treatment of chronic maxillary sinusitis. Clinical and microbiological effectiveness and penetration into sinuses examination].

Orendorz-Fraczkowska K, Bochnia M, Dziewiszek W, Stankiewicz M, Smutnicka D.

Otolaryngol Pol. 2005;59(4):517-22. Polish.

PMID:
16273854
18.

Resistant organisms and otitis media.

Dagan R, Regev-Yochay G, Rubinstein E.

Pediatr Infect Dis J. 2005 Sep;24(9):849; author reply 849-51. No abstract available.

PMID:
16148862
20.

Cefprozil-induced rash in infectious mononucleosis.

Baciewicz AM, Chandra R.

Ann Pharmacother. 2005 May;39(5):974-5. Epub 2005 Apr 12. No abstract available.

PMID:
15827073
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk